kabutan

Cyfuse Biomedical, The Current Fiscal Year's Net Income to Widen

Fri Feb 13, 2026 3:00 pm JST Earnings

4892 Cyfuse Biomedical K.K. 【J-GAAP】

Earnings Report

Cyfuse Biomedical K.K. <4892> [TSE Growth] announced its financial results in the afternoon session on February 13th (15:00). The net loss (non-consolidated) for the fiscal year ended December 2025 was loss of 0.76 billion yen, a reduction in the deficit compared to loss of 0.87 billion yen in the previous term. For the fiscal year ending December 2026, the net loss is expected to be loss of 1.05 billion yen. This will mark the fifth consecutive term of losses.

In the most recent three-month period, from October to December (4Q), the net loss improved to a deficit of 0.12 billion yen (compared to a loss of 0.20 billion yen in the same period last year). The operating profit/loss margin improved from -792.9% in the same period last year to -82.2%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 61 -697 -586 -589 -75.4 0 Feb 14, 2024 J-GAAP
Dec, 2024 54 -896 -869 -872 -108.3 0 Feb 14, 2025 J-GAAP
Dec, 2025 230 -828 -761 -763 -86.8 0 Feb 13, 2026 J-GAAP
YoY +325.9% +7.6% +12.4% +12.5% +19.9%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance 230 -828 -761 -763 -86.8 0 Jan 22, 2026 J-GAAP
Dec, 2025 Results 230 -828 -761 -763 -86.8 0 Feb 13, 2026 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% +0.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 29 -471 -401 -402 -48.9 0 Aug 14, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 54 -896 -869 -872 -108.3 0 Feb 14, 2025 J-GAAP
Dec, 2025 230 -828 -761 -763 -86.8 0 Feb 13, 2026 J-GAAP
Dec, 2026 Guidance 278 -1,081 -1,056 -1,059 -106.2 0 Feb 13, 2026 J-GAAP
YoY +20.9% -30.6% -38.8% -38.8% -22.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 28 -222 -207 -208 -25.8 -792.9 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 24 -240 -162 -162 -19.9 -1,000.0 May 15, 2025 J-GAAP
Apr - Jun, 2025 5 -231 -239 -240 -29.2 -4,620.0 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 32 -218 -234 -235 -27.6 -681.3 Nov 14, 2025 J-GAAP
Oct - Dec, 2025 169 -139 -126 -126 -14.3 -82.2 Feb 13, 2026 J-GAAP
YoY +503.6% +37.4% +39.1% +39.4% +44.5%

Related Articles